Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Amlodipine-based therapy is still a better treatment for uncomplicated hypertension than atenolol-based therapy, even in patients with higher baseline heart rates, according to…
NEW YORK (Reuters Health) – Postmenopausal breast cancer patients taking aromatase inhibitors have increased risks for carpal tunnel syndrome and new or worsening arthralgia, two studies published online…
NEW YORK (Reuters Health) – Antiretroviral therapy does not adversely affect lung function in HIV-infected patients and may actually have a beneficial effect, according to study findings presented…
NEW YORK (Reuters Health) – Starting estrogen-progestogen therapy close to menopause may increase the risk of breast cancer, even with short-duration treatment, according to a report in the…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), the antiarrhythmic dronedarone is less effective than amiodarone at maintaining sinus rhythm, but it has fewer adverse…
NEW YORK (Reuters Health) – Although dimenhydrinate can reduce vomiting in children with acute gastroenteritis, it does not improve oral rehydration or clinical outcomes, according to a report…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Perioperative corticosteroids reduce the risk of postoperative atrial fibrillation (AF) by more than 50% in patients undergoing cardiac surgery, according to a meta-analysis…
NEW YORK (Reuters Health) – Findings from a systematic review indicate that while tamoxifen, raloxifene, and tibolone all reduce the risk of primary breast cancer, the drugs differ…
NEW YORK (Reuters Health) – A dexamethasone-based protocol can cut the risk of relapse and improve survival in high-risk children with acute lymphoblastic leukemia (ALL), with fewer side…
